Category 1 preparations, made in less controlled environments, get shorter BUDs
Intact skin is engineered to keep things out
With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an "Innovative Global Healthcare Company Contributing to the Sustainable Development of Society." For more information, please visit: www.daiichisankyo.com
A study by Forsling et al
As GLP-1 therapies gain popularity for their non-invasive delivery and broad systemic benefits, global and Indian pharma companies alike are racing not only to stake a claim in the booming metabolic disorders marketbut also to explore potential repositioning across multiple chronic conditions
For purification, lysates were incubated with 1 mL of glutathione affinity resin (Cat